Kansas Poised for Full Kratom Ban as HB 2365 Heads to Governor

Kansas Poised for Full Kratom Ban as HB 2365 Heads to Governor

TOPEKA, KS – March 28, 2026 – The future of kratom in Kansas hangs in the balance as House Bill 2365 (HB 2365), which seeks to classify kratom as a Schedule I controlled substance, has successfully passed both chambers of the state legislature and now awaits the governor's signature. This legislative action, solidified by a 76-49 vote in the House and a 34-5 vote in the Senate, marks a significant shift towards an outright prohibition of the plant across Kansas.

The core of the legislative push centers on concerns surrounding 7-hydroxymitragynine (7-OH), a compound derived from the kratom leaf, which health officials and law enforcement warn can be highly potent and potentially addictive. Proponents of the ban argue that a blanket prohibition is necessary to prevent "bad actors" from exploiting loopholes and to simplify enforcement. However, critics contend that classifying all kratom, including the natural leaf, as a Schedule I drug alongside substances like heroin, is an extreme measure that fails to distinguish between natural kratom and potentially dangerous synthetic derivatives.

For kratom merchants and consumers, the implications of HB 2365 are profound. If signed into law, it would effectively criminalize the possession, sale, and manufacturing of all kratom products statewide. This means businesses currently operating in Kansas, or those shipping kratom products into the state, would be forced to immediately cease all related activities to avoid severe legal penalties, including substantial fines and potential criminal charges. Consumers who rely on kratom, some reportedly using it as an alternative for pain relief or as an "off-ramp" from opioids, would lose access to a product they consider vital. This move stands in stark contrast to previous legislative attempts in Kansas, like House Bill 2230, which aimed to establish a Kratom Consumer Protection Act (KCPA) to regulate, rather than ban, the substance.

For high-risk merchants navigating the complex and often fluid kratom regulatory landscape, the Kansas situation serves as a critical reminder of the importance of vigilance. In a state with an outright ban, Certificates of Analysis (COAs) and lab testing become irrelevant for legal sales, as the product itself is prohibited. However, for merchants operating in jurisdictions with existing or pending Kratom Consumer Protection Acts (KCPAs), these compliance measures are absolutely essential. Reputable businesses in regulated markets must continue to conduct rigorous third-party lab testing to ensure products are free from contaminants like heavy metals and pathogens, and to accurately verify alkaloid content, particularly levels of mitragynine and 7-OH.

Furthermore, in states where KCPAs are in effect, regulatory compliance typically mandates age restrictions (often 21 and older), prohibits adulterated or contaminated products, sets limits on specific alkaloid concentrations, and requires clear, accurate labeling with warning information and safe usage instructions. High-risk merchants must remain hyper-aware of the specific legal status of kratom in every state and locality they serve, as the patchwork of laws—from outright bans to robust regulatory frameworks—continues to evolve rapidly. The Kansas outcome underscores the imperative for adaptability and a proactive approach to compliance in this dynamic industry.